Cardio Diagnostics Holdings, Inc. CDIO

1.95 0.04 2.09% as of 25 Sep
Market cap
$5.7M
P/E
0.0×
Dec '17 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 0.00 0.00 0.00 706.27 318.47
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00
P/Operating CF
— (7,957.53) (1.09) (23.00) (17.70) (3.48)
P/B ratio
— 3,506.12 0.79 13.11 2.58 0.68
Price to Tangible BV
— 3,506.12 0.80 13.20 2.58 0.68
EV/Sales
— 0.00 0.00 0.00 481.99 (24.52)
EV/EBITDA
— 0.00 0.16 0.00 0.00 0.06
EV/Operating CF
— 0.00 0.14 (6.61) (3.37) 0.06
EV/FCF
— 0.00 0.14 (6.00) (3.23) 0.06
Quick Ratio
— 15.15 2.11 1.53 12.42 8.46
Current Ratio
— 23.70 3.02 3.29 13.92 9.79
Net Debt/EBITDA
— 0.85 0.91 0.18 0.97 0.84
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
— 0.00 0.00 0.00 0.00 0.00
Asset Turnover
— 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income
— 0.94 1.09 0.68 0.60 0.88
Capex/Depreciation
— 0.00 0.00 (5.16) (0.78) (0.47)
Interest Coverage
— 0.00 0.00 0.00 0.00 0.00
ROE
— 0.00% (173.60%) (230.77%) (133.97%) (78.62%)
ROA
— (112.60%) (126.80%) (156.40%) (111.20%) (70.70%)
ROIC
— (69.83%) (1,543.33%) (270.31%) (302.18%) (217.55%)
Return on Tangible Assets
— (80.61%) (118.36%) (335.54%) (94.92%) (108.02%)
Average Days of Receivables
— 365.00 0.00 106.73 194.53 199.76
Research and Development Expense of Revenue
— 3,500.00% 4,040.00% 849.12% 653.30% 4,332.43%
Selling, General and Administrative Expense of Revenue
— 63,766.67% 449,300.00% 41,492.40% 23,361.32% 39,138.51%
Intangible Assets out of Total Assets
0.00 0.05 0.01 0.00 0.00 0.00
Share Based Compensation of Revenue
— 6,666.67% 0.00% 7,481.29% 7,424.64% 744.59%
Graham Net Nets
— (0.03) 1.16 0.03 0.31 1.08
Graham Number
— 0.00 0.00 0.00 0.00 0.00
Earnings Yield
— (3.97%) (137.37%) (21.50%) (34.90%) (137.27%)
Free Cash Flow Yield
— 0.00% (150.07%) (16.11%) (21.13%) (124.63%)
Revenue per Share
— 0.02 0.01 0.04 0.04 0.01
Operating CF per Share
— (15.12) (49.52) (13.43) (5.57) (3.27)
Capex per Share
— 0.00 0.00 (1.36) (0.24) (0.11)
Free Cash Flow per Share
— (15.12) (49.52) (14.79) (5.81) (3.38)
Cash per Share
— 13.25 40.05 3.04 8.74 2.92
Shareholders Equity per Share
— 27.60 41.85 7.00 10.67 3.98
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 27.60 41.85 7.00 10.67 3.98
Free Cash Flow
— (0.59) (5.09) (6.25) (5.21) (5.91)
Working Capital
— 0.77 3.94 1.92 8.16 5.32
Capital Expenditures
— (0.11) (0.08) (0.58) (0.21) (0.19)
Net Current Asset Value
— 0.77 3.94 1.26 7.73 5.13
EV/EBIT
— 0.00 0.16 0.00 0.00 0.06
Capex to Sales
— 0.00 0.00 33.67 6.15 12.66
Net Profit Margin
— (68,933.33%) (466,100.00%) (48,987.13%) (24,021.49%) (43,906.76%)
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 0.00 0.00 0.20 0.41 0.57
Cash ROIC
— (37.02%) (60.47%) (147.21%) (32.59%) (53.19%)
Accounts Receivable Turnover
— 0.00 0.00 5.80 2.96 1.11
Accounts Payable Turnover
— — 0.00 0.00 0.00 0.00
Inventory Turnover
— — 0.00 — — —
Average Days of Payables
— 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — 0.00 — — —
Average Receivables
— — — 0.00 0.01 0.01
Average Payables
— — 0.57 0.67 0.17 0.09
Average Assets
— 0.55 3.68 5.36 7.54 9.19
Average Common Equity
— — 2.68 3.63 6.26 8.27

Fold the line items

Columns are period end dates